COST-EFFECTIVENESS OF SORAFENIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW

被引：0
|
作者：
Taheri, S. [1 ]
Motevalli, M. H. [1 ]
Peiravian, F. [1 ]
Yousefi, N. [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharma Management, Tehran, Iran
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN168
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
    Yuen, Sydney C.
    Amaefule, Adaeze Q.
    Kim, Hannah H.
    Owoo, Breanna-Verissa
    Gorman, Emily F.
    Mattingly, T. Joseph I. I. I. I.
    PHARMACOECONOMICS-OPEN, 2022, 6 (01) : 9 - 19
  • [2] A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
    Sydney C. Yuen
    Adaeze Q. Amaefule
    Hannah H. Kim
    Breanna-Verissa Owoo
    Emily F. Gorman
    T. Joseph Mattingly
    PharmacoEconomics - Open, 2022, 6 : 9 - 19
  • [3] Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
    Gupta, Nidhi
    Verma, Rohan K.
    Prinja, Shankar
    Dhiman, Radha K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (04) : 468 - 475
  • [4] Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
    Camma, Calogero
    Cabibbo, Giuseppe
    Petta, Salvatore
    Enea, Marco
    Iavarone, Massimo
    Grieco, Antonio
    Gasbarrini, Antonio
    Villa, Erica
    Zavaglia, Claudio
    Bruno, Raffaele
    Colombo, Massimo
    Craxi, Antonio
    HEPATOLOGY, 2013, 57 (03) : 1046 - 1054
  • [5] COST-EFFECTIVENESS OF SORAFENIB FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW
    Taheri, S.
    Motevalli, M. H.
    Peiravian, F.
    Yousefi, N.
    VALUE IN HEALTH, 2018, 21 : S42 - S42
  • [6] Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review
    Ruggeri, Matteo
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2012, 5 : 49 - 54
  • [7] Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
    Zhang, Pengfei
    Yang, Yu
    Wen, Feng
    He, Xiaofeng
    Tang, Ruilei
    Du, Zedong
    Zhou, Jing
    Zhang, Jian
    Li, Qiu
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (07) : 853 - 859
  • [8] Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
    Xie, Bingru
    Wang, David H.
    Spechler, Stuart Jon
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (05) : 1122 - 1129
  • [9] Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
    Bingru Xie
    David H. Wang
    Stuart Jon Spechler
    Digestive Diseases and Sciences, 2012, 57 : 1122 - 1129
  • [10] Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost-effectiveness analysis
    Cai, Hongfu
    Zhang, Longfeng
    Li, Na
    Zheng, Bin
    Liu, Maobai
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (08) : 553 - 562
12345